Northwest Clinical Research Center

Improving Lives Through Research

Contact Us

425.453.0404

US FDA Approved Trials For Generalized Anxiety Disorder

Northwest Clinical Research Center offers a variety of Generalized Anxiety Disorder studies evaluating potential medication that has been approved for investigation by the US FDA (Food and Drug Administration).

If you are interested in participating in a clinical research study, you can schedule a no cost, in-person evaluation to meet with our doctors and see if our studies are the right fit for you.

To participate in a clinical trial, please give us a call to schedule at 425-453-0404.

For specific details of our ongoing trials, please see the links below, provided by the National Library of Medicine:

 

Generalized Anxiety Disorder

M25-099: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932 as an Adjunct to Antidepressant Therapies in the Treatment of Subjects with Generalized Anxiety Disorder who have had an Inadequate Response to Antidepressant Therapies

NCT06846320

TRIAL DETAILS

ITI-1284-301: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as an Adjunctive Treatment in Patients with Generalized Anxiety Disorder Who Have an Inadequate Response to Generalized Anxiety Disorder Treatment

NCT06480383

TRIAL DETAILS

ITI-1284-302: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as Monotherapy Treatment in Patients with Generalized Anxiety Disorder Who Have Had Inadequate Response to Generalized Anxiety Disorder Treatment

NCT06701903

TRIAL DETAILS

Study Evaluation Process

  • Screening: Determine eligibility and safety through medical examinations, questionnaires, and interviews.
  • Informed Consent: Receive detailed information about the trial, including risks and benefits.
  • Treatment: Receive investigational medication and placebo, and follow the trail protocol regarding current treatments and medications.
  • Monitoring: Close monitoring of conditions and side effects through check-ups, laboratory tests, EKG’s and assessments.

NWCRC in Bellevue, WA. Research and medical studies patient lounge.

CONTACT US

To be contacted about this study, fill out the contact form or call 425-453-0404.

This field is for validation purposes and should be left unchanged.
We complete all visits in person. Do you live within 50 miles of Bellevue, WA?(Required)


Are you interested in participating in clinical trials?(Required)


Please indicated which study you are interested in.(Required)